US Stocks
/
Monopar Therapeutics Inc. Share Price

Monopar Therapeutics Inc. Share Price

NASDAQ: MNPR
$83.72
-$0.12 (-0.14%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Monopar Therapeutics Inc. Stock Performance

Open
$83.40
Prev. Close
$83.84
Circuit Range
N/A
Day Range
$81.35 - $85.39
Year Range
$50.33 - $123.95
Volume
10,186
Average Traded
$82.82

Monopar Therapeutics Inc. Share Price Today

As of 9 October 2026, Monopar Therapeutics Inc.'s share price is $83.72. The stock opened at $83.40, compared to its previous close of $83.84. During today's trading session, Monopar Therapeutics Inc.'s share price traded between $81.35 and $85.39, with an average price of $83.37. Over the past 52 weeks, the stock has recorded a high of $123.95 and a low of $50.33. In terms of performance, Monopar Therapeutics Inc.'s share price has risen by 58.83% over the last six months and is down 2.31% on a year-on-year basis.

Monopar Therapeutics Inc. Share Price Chart

$81.35$85.39
L
Show Current Price
H

Monopar Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.66
Revenue (TTM)
$0.00
Return On Equity (TTM)
-13.64%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-54.36%

Monopar Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.44-$5.20-$3.89-$5.31
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-51.16%25.19%-36.50%

Monopar Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.52-$8.40-$15.59-$13.72
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A20.15%-85.60%11.99%

About Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.

Monopar Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$79.41
$84.74
+6.46%
Sep 2026
$113.19
$79.60
-30.67%
Aug 2026
$107.40
$114.82
+6.10%
Jul 2026
$95.57
$108.22
+17.05%
Jun 2026
$65.00
$92.46
+42.80%
May 2026
$51.35
$64.75
+22.84%
Apr 2026
$56.07
$52.71
-4.16%
Mar 2026
$53.38
$55.00
+0.25%
Feb 2026
$62.62
$54.87
-9.77%
Jan 2026
$66.06
$60.80
-6.57%
Dec 2025
$82.99
$65.08
-24.01%
Nov 2025
$80.51
$85.65
-0.06%

MNPR Share Price FAQs

What is Monopar Therapeutics Inc. share price today?

chevron-up
Monopar Therapeutics Inc. share price today is $83.72 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Monopar Therapeutics Inc. stock?

chevron-up
The 52 week high of Monopar Therapeutics Inc. stock is $123.95, while the 52 week low is $50.33 as of 9 Oct '26.

What is MNPR's net income for the last quarter?

chevron-up
MNPR's net income for the last quarter is -5.31B USD.

What is the 5 year returns of MNPR?

chevron-up
The 5 year returns of MNPR is 248.83% as on 9 Oct '26.

What is the high & low stock price of MNPR today?

chevron-up
MNPR stock price hit a high of $85.39 and low of $81.35 as of 9 Oct '26.

Can I buy MNPR shares in India?

chevron-up
Yes. You can buy MNPR in India by opening an international trading account.